Mid-term subclinical myocardial injury detection in patients who recovered from COVID-19 according to pulmonary lesion severity.
cardiac
coronavirus
injury
recovery
strain
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
05
2022
accepted:
11
08
2022
entrez:
4
11
2022
pubmed:
5
11
2022
medline:
5
11
2022
Statut:
epublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) may cause damage to the cardiovascular system during the acute phase of the infection. However, recent studies reported mid- to long-term subtle cardiac injuries after recovering from acute coronavirus disease 2019 (COVID-19). This study aimed to determine the relationship between the severity of chest computed tomography (CT) lesions and the persistence of subtle myocardial injuries at mid-term follow-up of patients who recovered from COVID-19 infection. All patients with COVID-19 were enrolled prospectively in this study. Sensitive troponin T (hsTnT) and chest CT scans were performed on all patients during the acute phase of COVID-19 infection. At the mid-term follow-up, conventional transthoracic echocardiograph and global longitudinal strain (GLS) of the left and right ventricles (LV and RV) were determined and compared between patients with chest CT scan lesions of < 50% (Group 1) and those with severe chest CT scan lesions of greater or equal to 50% (Group 2). The mean age was 55 ± 14 years. Both LV GLS and RV GLS values were significantly decreased in group 2 ( Patients with severe chest CT scan lesions are more likely to develop subclinical myocardial damage. Transthoracic echocardiography (TTE) could be recommended in patients recovering from COVID-19 to detect subtle LV and RV lesions.
Sections du résumé
Background
UNASSIGNED
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) may cause damage to the cardiovascular system during the acute phase of the infection. However, recent studies reported mid- to long-term subtle cardiac injuries after recovering from acute coronavirus disease 2019 (COVID-19). This study aimed to determine the relationship between the severity of chest computed tomography (CT) lesions and the persistence of subtle myocardial injuries at mid-term follow-up of patients who recovered from COVID-19 infection.
Methods
UNASSIGNED
All patients with COVID-19 were enrolled prospectively in this study. Sensitive troponin T (hsTnT) and chest CT scans were performed on all patients during the acute phase of COVID-19 infection. At the mid-term follow-up, conventional transthoracic echocardiograph and global longitudinal strain (GLS) of the left and right ventricles (LV and RV) were determined and compared between patients with chest CT scan lesions of < 50% (Group 1) and those with severe chest CT scan lesions of greater or equal to 50% (Group 2).
Results
UNASSIGNED
The mean age was 55 ± 14 years. Both LV GLS and RV GLS values were significantly decreased in group 2 (
Conclusion
UNASSIGNED
Patients with severe chest CT scan lesions are more likely to develop subclinical myocardial damage. Transthoracic echocardiography (TTE) could be recommended in patients recovering from COVID-19 to detect subtle LV and RV lesions.
Identifiants
pubmed: 36330010
doi: 10.3389/fcvm.2022.950334
pmc: PMC9623290
doi:
Types de publication
Journal Article
Langues
eng
Pagination
950334Informations de copyright
Copyright © 2022 Chamtouri, Kaddoussi, Abroug, Abdelaaly, Lassoued, Fahem, Cheikh'Hmad, Ben Abdallah, Jomaa, Ben Hamda and Maatouk.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Korean Circ J. 2019 Oct;49(10):960-972
pubmed: 31074229
Circ Res. 2020 May 8;126(10):1443-1455
pubmed: 32252591
J Am Coll Cardiol. 2020 Oct 27;76(17):1978-1981
pubmed: 33092733
J Clin Med. 2021 Jun 08;10(12):
pubmed: 34200990
J Thromb Thrombolysis. 2020 Jul;50(1):157-164
pubmed: 31667788
Future Cardiol. 2021 Jul;17(4):663-667
pubmed: 32749151
JACC Cardiovasc Imaging. 2020 Aug;13(8):1859
pubmed: 32762893
Echocardiography. 2020 Dec;37(12):2029-2039
pubmed: 32964483
J Geriatr Cardiol. 2013 Mar;10(1):102-9
pubmed: 23610580
J Am Coll Cardiol. 2020 Sep 8;76(10):1244-1258
pubmed: 32652195
Cardiovasc Diabetol. 2016 Feb 03;15:22
pubmed: 26842466
J Intensive Care. 2021 Jan 12;9(1):9
pubmed: 33436101
J Crit Care. 2012 Jun;27(3):319.e9-15
pubmed: 21855287
JACC Cardiovasc Imaging. 2018 Aug;11(8):1196-1201
pubmed: 30092974
Am J Physiol Heart Circ Physiol. 2020 Jan 1;318(1):H156-H164
pubmed: 31756118
Int J Cardiovasc Imaging. 2021 Jan;37(1):135-144
pubmed: 32803484
Heart. 2015 Jul;101(13):1061-6
pubmed: 25935767
Acta Pharmacol Sin. 2021 Oct;42(10):1567-1574
pubmed: 33510459
Circ Cardiovasc Imaging. 2016 Feb;9(2):e003866
pubmed: 26860970
Am J Emerg Med. 2021 Jun;44:352-357
pubmed: 32331955
JACC Cardiovasc Imaging. 2020 Nov;13(11):2287-2299
pubmed: 32654963
JACC Basic Transl Sci. 2020 Apr 10;5(5):518-536
pubmed: 32292848
J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320927851
pubmed: 32431227
Heart. 2020 Aug;106(15):1127-1131
pubmed: 32499236
Aging Dis. 2020 May 13;11(4):874-894
pubmed: 32765952